Synthesis and evaluation of thieno[3,2-d]pyrimidine derivatives as novel FMS inhibitors
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (2) , 271-275
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular CarcinomaMolecular Cancer Therapeutics, 2017
- Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapyJournal for ImmunoTherapy of Cancer, 2017
- CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade TherapyCancer Research, 2015
- Tumor-Associated Macrophages as Major Players in the Tumor MicroenvironmentCancers, 2014
- Antibody against CSF-1 receptor protects bone and cartilageNature Reviews Rheumatology, 2014
- The M1 and M2 paradigm of macrophage activation: time for reassessmentF1000Prime Reports, 2014
- Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152Molecular Cancer, 2012
- Effects of the cFMS Kinase Inhibitor 5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in Normal and Arthritic RatsThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Macrophages and their products in rheumatoid arthritisCurrent Opinion in Rheumatology, 2007
- The role of macrophage stimulating factor M-CSF in bone resorptionOsteoporosis International, 1993